Nasdaq.com

Biohaven, Pfizer enter up to $1.24 bln deal to market

A dds details on the deal, drugs. Nov 9 (Reuters) - Pfizer Inc PFE.N will acquire overseas marketing rights to two migraine drugs from Biohaven Pharmaceutical Holding Co BHVN.N for up to $1.24

Actived: 1 days ago

URL: nasdaq.com


3 Big Drug/Biotech Outperformers Worth Keeping an Eye On

(9 days ago) Lilly boasts a solid portfolio of new drugs in diabetes, autoimmune diseases and cancer. Lilly’s revenue growth in the first half of 2021 was driven by higher demand for drugs like Trulicity

Category:  Cancer,  Diabetes Go Now


Bristol Myers (BMY) Top Drugs Maintain Momentum Amid

(4 days ago) Bristol Myers (BMY) Top Drugs Maintain Momentum Amid Competition. Bristol Myers BMY, one of the leading global specialty biopharmaceutical companies, has performed well in the second half of the

Category:  Pharmaceutical Go Now


U.S. FDA aiming for speedy review of Omicron vaccines and

(9 days ago) The U.S. Food and Drug Administration is setting up guidelines to expedite reviews of COVID-19 vaccines and drugs targeting the Omicron variant, the Wall Street Journal reported https://on.wsj.com

Category:  Health Go Now


Jazz Pharma (JAZZ) Gets FDA Approval for Leukemia Drug

(2 days ago) Jazz has a strong oncology portfolio with several hematology/oncology drugs in its portfolio, aiding growth and diversification. The company is developing a few oncology candidates and is also

Category:  Health Go Now


UCB Signs Up To $1.5 Bln Deal With Novartis To Co-develop

(Just Now) (RTTNews) - The Belgian pharmaceutical company, UCB (UCB.BR), said on Thursday that it has inked an agreement of up to $1.5 billion with Novartis(NVS) to co-develop and commercialize its two

Category:  Pharmaceutical Go Now


A Pfizer Drug Moves Closer to Approval in Another

(3 days ago) Published. Nov 2, 2021 8:10AM EDT. When investors think of Pfizer (NYSE: PFE) these days, they tend to think first of Comirnaty, the COVID-19 vaccine that it developed in collaboration with

Category:  Health Go Now


4 Small Drug Stocks That Hold Promise Despite Industry

(8 days ago) Sales of some drugs/vaccines/products are expected to have been hurt by business disruption due to COVID-19 in the third quarter despite an ongoing recovery from the earlier impacts of the pandemic.

Category:  Health Go Now


Covid, guns, drugs fuel irreparable labor shortage Nasdaq

(1 days ago) Covid, guns, drugs fuel irreparable labor shortage. WASHINGTON (Reuters Breakingviews) - The last two years have caused lasting damage to the U.S. workforce. A record 4.3 million people quitting

Category:  Health Go Now


Tuesday Sector Laggards: Drugs, Biotechnology Stocks Nasdaq

(6 days ago) In trading on Tuesday, drugs shares were relative laggards, down on the day by about 1.8%. Helping drag down the group were shares of Cassava Sciences, down about 9.4% and shares of Prometheus

Category:  Health Go Now


EXCLUSIVE-Amid spike in cases, EU to shortly approve first

(Just Now) The European Union drugs regulator is set to authorise the use of two monoclonal antibodies to treat COVID-19 patients in coming days, two EU sources told Reuters, in its first approvals of such

Category:  Health Go Now


FDA approves Amgen drug for lung cancer with specific

(7 days ago) Cancer drugs are typically developed at the highest tolerable dose, but some oncologists have urged the FDA to do more to require drugmakers to optimize dosing. "Our sense is this is going to

Category:  Cancer Go Now


Deciphera (DCPH) to Prioritize Key Pipeline Drugs, Cut

(8 days ago) Deciphera (DCPH) to Prioritize Key Pipeline Drugs, Cut Jobs. Deciphera Pharmaceuticals, Inc. DCPH has announced a corporate restructuring plan to prioritize the development of select clinical

Category:  Pharmaceutical Go Now


Monday Sector Leaders: Shipping, Drugs Nasdaq

(2 days ago) Monday Sector Leaders: Shipping, Drugs. In trading on Monday, shipping shares were relative leaders, up on the day by about 3.1%. Leading the group were shares of Euroseas, up about 23.5% and

Category:  Health Go Now


Novartis expects new drugs to boost sales by at least 4%

(8 days ago) Novartis expects new drugs to boost sales by at least 4% until 2026. Novartis is confident of delivering annual revenue growth of 4% or higher until 2026, as it banks on multi-billion dollar sales

Category:  Health Go Now


Bristol Myers' (BMY) Plaque Psoriasis Drug Filings Get

(1 days ago) Bristol-Myers is looking to counter the generic threat and competition to its key drugs through new drug approvals and diversification of the top …

Category:  Health Go Now


Pfizer, Merck launch new trials of oral COVID-19 drugs

(6 days ago) A dds details, background, recasts. Sept 1 (Reuters) - Pfizer Inc PFE.N and Merck & Co Inc MRK.N announced on Wednesday new trials of their experimental oral antiviral drugs for …

Category:  Health Go Now


Monday Sector Leaders: Specialty Retail, Drugs Nasdaq

(Just Now) Monday Sector Leaders: Specialty Retail, Drugs. Contributor. BNK Invest BNK Invest. Published. Aug 2, 2021 12:06PM EDT. I n trading on Monday, specialty retail shares were relative leaders, up on

Category:  Health Go Now


Bristol Myers Squibb Just Got Some Great Regulatory News

(9 days ago) Zeposia's list price for a year's supply is $89,000 in the U.S. Since drugs in the EU are a third to half the cost of drugs in the U.S., I will assume that the list price is $30,000 in the EU.

Category:  Health Go Now


The 19 Best-Selling Prescription Drugs of All-Time Nasdaq

(6 days ago) Among the bounty of approved Food and Drug Administration drugs is the crème de la crème: blockbusters. A blockbuster drug is one that generates $1 billion or more in annual sales.

Category:  Health Go Now


Recovery in Drugs Sales to Aid AbbVie's (ABBV) Q3 Earnings

(8 days ago) The drugs showed robust sequential revenue growth in the first two quarters of 2021. These two drugs are likely to have partially offset some loss of sales of the company’s flagship drug, Humira

Category:  Health Go Now


AbbVie's (ABBV) Migraine Prevention Drug Qulipta Gets FDA

(1 days ago) The migraine market is heavily crowded with several anti-CGRP drugs like Amgen’s AMGN Aimovig, Lilly’s LLY Emgality and Teva’s Ajovy, which are …

Category:  Health Go Now


Regeneron, Lilly Get New COVID Drug Deals From Government

(9 days ago) Regeneron Pharmaceuticals REGN and Eli Lilly & Company LLY announced new agreements with the U.S. government to supply additional doses of their respective COVID-19 antibody drugs amid greater

Category:  Pharmaceutical Go Now


Vertex (VRTX) Up on Kidney Disease Drug's Success in Phase

(Just Now) Published. Dec 2, 2021 10:13AM EST. Vertex Pharmaceuticals Incorporated VRTX announced positive data from a phase II study evaluating VX-147, its oral small molecule medicine for treating APOL1

Category:  Pharmaceutical Go Now


Mirati (MRTX), Verastem to Study Cancer Drugs for NSCLC

(4 days ago) Mirati Therapeutics MRTX announced a non-exclusive deal with Verastem Oncology VSTM to conduct a clinical study on a combination of adagrasib, Mirati’s leading KRAS inhibitor candidate, and VS

Category:  Health Go Now


Merck Receives Another Boost for Its Top-Selling Drug Nasdaq

(6 days ago) Merck's best-selling drug is already approved in Europe, the U.S., and elsewhere for a wide variety of indications, including melanoma, lung cancer, head and neck cancer, and Hodgkin's lymphoma

Category:  Cancer,  Lung Go Now


Ligand's (LGND) Drug-Developing Technologies Holds

(9 days ago) Ligand also earns royalties on the sales of drugs developed using its Captisol technology, including Amgen’s AMGN blockbuster drug, Kyprolis. LGND’s another source of revenues is the sale of

Category:  Health Go Now


Pfizer's rheumatoid arthritis drug shows benefit in COVID

(2 days ago) Pfizer Inc said on Wednesday its oral rheumatoid arthritis drug Xeljanz reduced death or respiratory failure in hospitalized COVID-19 patients with pneumonia in Brazil, meeting the study's main goal.

Category:  Hospital Go Now


CSL’s Swiss drug punt looks like a bad trip Nasdaq

(4 days ago) CSL’s Swiss drug punt looks like a bad trip. LONDON (Reuters Breakingviews) - CSL’s Swiss expedition risks derailing its winning streak. The $99 billion Australian flu-jab maker is in talks to

Category:  Health Go Now


WHO Guidelines Put Spotlight on Arthritis Drugs Actemra

(6 days ago) Drugs like Actemra and Kevzara work by inhibiting the effects of interleukin-6, a type of protein called a cytokine that urges the body to mount an inflammatory response.

Category:  Health Go Now


4 Big Drug, Biotech Stocks Set to Beat Q3 Earnings

(2 days ago) 4 Big Drug, Biotech Stocks Set to Beat Q3 Earnings Estimates. Several big pharma companies have reported their third-quarter results so far. The results demonstrated that sales of key drugs

Category:  Health Go Now


Monday Sector Laggards: Drugs, Cigarettes & Tobacco Stocks

(Just Now) In trading on Monday, drugs shares were relative laggards, down on the day by about 1.8%. Helping drag down the group were shares of Revance Therapeutics, off about 41.3% and shares of Omeros off

Category:  Health Go Now


Risk of patient overlap between Wegovy and Saxenda obesity

(9 days ago) Novo Nordisk's new obesity drug Wegovy, far more efficient at causing weight loss in patients than similar drugs on the market, could capture sales of …

Category:  Health Go Now


Tuesday Sector Laggards: Precious Metals, Drugs Nasdaq

(1 days ago) Also lagging the market Tuesday are drugs shares, down on the day by about 0.8% as a group, led down by Abeona Therapeutics, trading lower by about 16% and Unity Biotechnology, trading lower by

Category:  Health Go Now


Jazz Pharma (JAZZ) Q3 Earnings Beat, New Drugs Drive Sales

(7 days ago) The increase was driven by sales of new drugs and drugs added from the acquisition of GW Pharmaceuticals. Net product sales increased 40.0% from the …

Category:  Pharmaceutical Go Now


Eli Lilly (LLY) Q3 Earnings Miss, COVID Drugs Drive Sales

(7 days ago) Eli Lilly (LLY) Q3 Earnings Miss, COVID Drugs Drive Sales. Eli Lilly & Company LLY reported third-quarter 2021 adjusted earnings per share of $1.94, which missed the Zacks Consensus Estimate of $1

Category:  Health Go Now


How Will Pfizer's (PFE) Key Drugs Impact Its Q3 Earnings

(6 days ago) However, sales of some key drugs like Chantix in the United States and Enbrel in international markets are likely to have declined in the third quarter, continuing the trend of the past few quarters.

Category:  Health Go Now


Biogen Considers Drastic Cost-Cutting Measures As

(9 days ago) (RTTNews) - Biotechnology company Biogen Inc. (BIIB) is considering drastic cost-cutting measures like layoffs, following the poor response to its Alzheimer drug …

Category:  Health Go Now


Biotech Stocks Facing FDA Decision In October 2021 Nasdaq

(3 days ago) The FDA has approved 39 novel drugs so far this year compared to 40 during the same period last year. A total of 53 novel drugs were approved …

Category:  Health Go Now


FDA Approves Livtencity As First Drug To Treat Post

(Just Now) (RTTNews) - The U.S. Food and Drug Administration has approved Takeda Pharmaceuticals Co. Ltd.'s Livtencity (maribavir) as the first drug to treat post-transplant cytomegalovirus or CMV in adults

Category:  Pharmaceutical Go Now


Biogen (BIIB) In-Licenses Rights to Multiple Sclerosis Drug

(Just Now) Biogen (BIIB) In-Licenses Rights to Multiple Sclerosis Drug. Biogen BIIB announced that it has entered into a license and collaboration agreement with China-based biopharmaceutical company

Category:  Pharmaceutical Go Now


Monday Sector Laggards: Education & Training Services, Drugs

(2 days ago) Also lagging the market Monday are drugs shares, down on the day by about 0.8% as a group, led down by NGM Biopharmaceuticals, trading lower by about 37.6% and Onconova Therapeutics, trading lower

Category:  Pharmaceutical Go Now


Biogen (BIIB) Ends Development of Anti-Tau Alzheimer's

(9 days ago) The drugs presently available just treat the symptoms of the disease. Several companies have failed to develop safe and effective treatment options to treat this deadly brain disease.

Category:  Health Go Now


Biogen's (BIIB) Oral MS Drug Vumerity Gets Approval in

(Just Now) Biogen has a strong portfolio of six MS drugs that generated approximately 70% of total revenues in the first nine months of 2021. However, Tecfidera sales declined almost 55% year over year.

Category:  Health Go Now

Top Categories

Popular Searched

 › Cvs pharmacy st thomas usvi

 › Peoples health drug formulary

 › Texas medical board pa license renewal

 › Drug testing welfare costs

 › Common medical coding errors

 › Mclaren health advantage provider directory

 › West plano medical associates

 › Best drugstore cream bronzer

 › Zip codes with medicare give back benefits

 › Kinney drug store weekly flyer

 › Nixon war on drugs act

 › Shoppers drug mart saskatoon

 › Fiorcet and barbituate drug screen

 › Sturdy north attleboro medical center

 › Diagnosis codes for medical necessity

Recently Searched

 › Fort jackson medical center

 › Medical voice recognition software

 › Medical transcription voice recognition software

 › Credentialing process for medical providers

 › Optum specialty pharmacy drug list

 › Starting a new pharmacy

 › Adventhealth medical group fl

 › Prescription drug definition fda

 › Behavioral health terminology abbreviations

 › Alcohol and drug use statistics

 › Wsu college of pharmacy library resources

 › Nursing drug calculation exam

 › Beaumont medical records fax

 › Aetna medicare rx by silverscript

 › Aetna prescription drug formulary